Sotyktu Dosage
Generic name: DEUCRAVACITINIB 6mg
Dosage form: tablet, film coated
Drug class: Selective immunosuppressants
Medically reviewed by Drugs.com. Last updated on Aug 30, 2024.
Recommended Evaluations and Immunizations Prior to Treatment Initiation
Evaluate patients for active and latent tuberculosis (TB) infection prior to initiating treatment with SOTYKTU. If positive, start treatment for TB prior to SOTYKTU use.
Update immunizations according to current immunization guidelines.
Frequently asked questions
- Sotyktu vs Otezla: How do they compare?
- How long does it take for Sotyktu to work?
- How long can I take Sotyktu for?
- How is Sotyktu given / administered?
More about Sotyktu (deucravacitinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (13)
- Drug images
- Side effects
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
See also:
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Otezla
Otezla (apremilast) is used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Vtama
Vtama (tapinarof) is a steroid-free, once-daily cream used to treat plaque psoriasis and atopic ...
Humira
Humira is a tumor necrosis factor blocker that is used to treat many inflammatory conditions such ...
Enbrel
Enbrel is used to treat rheumatoid arthritis, ankylosing spondylitis, and psoriasis. Learn about ...
Tremfya
Tremfya (guselkumab) injection is used to treat plaque psoriasis, psoriatic arthritis, ulcerative ...
Cosentyx
Cosentyx (secukinumab) is used to treat plaque psoriasis, psoriatic arthritis, ankylosing ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
